Long Term Administration Study of OPC-12759 Ophthalmic Suspension

Summary

The purpose of this study is to evaluate safety and efficacy of OPC-12759 ophthalmic suspension during 52 weeks in dry eye patients

Timeline

Start

2009-01

Primary completion

2010-09

Completion

2011-01

Outcome

Met primary endpoint

registry 2% Rebamipide Group; p <0.001; t-test, 2 sided; note: The p value represents the comparison between baseline data and data at Week 2 NCT00818324 ↗

Drugs

Indications